Yihong Li
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Extracellular vesicles in disease 5
- Peroxisome Proliferator-Activated Receptors 3
- Epigenetics and DNA Methylation 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 5
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Xiaodong MaJames R. BarkerQien XuZhe LiuYuanhui SongXingbo LiuRandall GemmenManish Kumar
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yihong Li
52 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 614
- Molecular Biology 883
- Biomaterials 132
- Pharmacology 167
- Immunology 175
Countries citing papers authored by Yihong Li
This map shows the geographic impact of Yihong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihong Li more than expected).
Fields of papers citing papers by Yihong Li
This network shows the impact of papers produced by Yihong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihong Li. The network helps show where Yihong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yihong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 13 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 13 | |
| 16 | 2019 | 13 | |
| 17 | 2016 | 199 | |
| 18 | 2014 | 23 | |
| 19 | 2011 | 38 | |
| 20 | 2010 | 228 |
About Yihong Li
Yihong Li is a scholar working on Biological Psychiatry, Cancer Research and Pharmacology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Microbial Natural Products and Biosynthesis (5 papers), Cancer-related molecular mechanisms research (5 papers), Extracellular vesicles in disease (5 papers), Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (614 citations), Molecular Biology (883 citations) and Biomaterials (132 citations). Yihong Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiaodong Ma, James R. Barker, Qien Xu, Zhe Liu, Yuanhui Song, Xingbo Liu, Randall Gemmen, Manish Kumar, Weichang Chen and Ken H. Young. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.